Abstract A 22-year-old 
Introduction
Since its fi rst description 150 years ago, only 11 cases of tracheal malignant melanoma, 6 primary and 5 metastatic, have been reported. [1] [2] [3] Mucosal melanomas originate from mucosal melanocytes of neuroectodermal origin and are more fatal than skin melanomas. 1 They can appear in the mucosa of the head and neck, esophagus, and larynx. 4 Many theories have been put forth in an attempt to explain the development of respiratory tract malignant melanomas. 5 Melanoblasts may migrate from the neural crest to the epidermis, hair follicles, oral cavity, nasopharynx, uvea, leptomeninges, inner ear, and even internal organs. Another theory postulates that respiratory cells are transformed to melanocytes (melanogenic metaplasia). Finally, some precursor cells, such as enterochromaffi n cells, are related to neuroendocrine cells and show melanocytic differentiation. 5, 6 We report a case of a mucosal malignant melanoma arising in the trachea.
Case report
A 22-year-old man was admitted to our clinic with diffi culty breathing and hoarseness. Laryngoscopy revealed a mass obstructing the trachea. The mass was mobile with respiration. Computed tomography (CT) of the neck showed the mass to be 1.5 × 2 cm, smoothbordered, solid, and heterogeneously contrast-enhancing (fi gure 1). Tracheotomy was performed below the level of the mass, between the third and fi fth rings of the trachea, with local anesthesia. General anesthesia was then maintained through the tracheotomy. Following a vertical incision, a pedunculated mass located 1 cm below the interarytenoid area was seen (fi gure 2, A). The mass was black and fi lled approximately 80% of the tracheal lumen. It was removed with a 5-mm margin of mucosa surrounding the base of the peduncle (fi gure 2, B). In the intraoperative frozen section, margins of the mucosa were reported to be intact. Paratracheal lymph node dissection was performed. The patient was decannulated on postoperative day 4, and no postoperative complications were seen.
On macroscopic examination, the mass had a slightly elevated, irregular surface with no difference in color from the surrounding mucosa. Histopathologic examination showed areas of mucosa-infi ltrating, nonpigmentary, large, atypical cells with balloon-like cytoplasm, suggesting malignancy. Hematoxylin-eosin staining revealed thinning and destruction of the respiratory epithelium with fi lling of the subepithelial area by atypical cells. An infi ltrating growth pattern was prominent. Masson-Fontana staining showed blackbrown melanin pigment in the atypical cells. S-100 protein, HMB-45, and Melan A antibodies, as well as cytoplasmic immunoreactivity, were found in the tumor cells. The lesion was pathologically classifi ed as "nodular-type mucosal malignant melanoma."
The resection borders were normal, and no metastatic cells were found in the dissected paratracheal lymph nodes.
A search for a primary site using cranial and thoracic CT, abdominal ultrasonography, and dermatologic examination revealed no lesion. The patient had no history of dermatologic lesions, no family history of cancer, and no history of smoking. Based on these fi ndings, we diagnosed him with stage I primary tracheal malignant melanoma. After more than 3 years of follow-up, no recurrence has been found.
Discussion
Head and neck mucosal melanomas are mostly seen in patients 70 to 80 years of age. 7 They are slightly more common in men than women. 4, 7 Of 84,836 cases of melanoma in the U.S. National Cancer Database, 1.3% were mucosal. 7 Among all malignant melanomas, 0.5 to 3% are seen in the head and neck mucosa, and only 3.8 to 7.4% of these are laryngeal. 8 Tracheal malignant melanomas are less common than laryngeal ones. 8 Histopathologic diagnosis of malignant melanoma is possible by identifying intracellular melanin. This is found in 50 to 70% of cases. 1, 4 Immunohistochemical methods are also helpful in diagnosis. Melanomas give a positive reaction with antivimentin, NKI/C-3, S-100, Melan A, and HMB-45 antibodies.
1 CEA-MAA, p97 MAA, and NGF-R antigens indicate an increased metastatic potential and poor prognosis. 1 In our case, cytoplasmic immunoreactivity with S-100, HMB-45, and Melan A antibodies was found.
Pathology cannot determine whether the melanoma is primary or metastatic. The criteria for the diagnosis of primary respiratory malignant melanomas are 5 :
1. The tumor should be solitary. Mucosal melanoma can also be distinguished from metastatic melanoma in that the latter is typically covered with an intact mucosa layer. 
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In our patient, no alternative primary lesions were discovered through radiologic and dermatologic investigations. The patient did not have a history of dermatologic lesion excision or a family history of cancer. The mass was solitary, and the surrounding mucosa was not normal. Therefore, the lesion was accepted as primary tracheal malignant melanoma.
Because mucosal melanomas of the head and neck are rarely seen and survival is short, it is diffi cult to determine optimal therapy for them.
Although primary and secondary mucosal melanomas of the head and neck have similar fi ndings, the difference in treatment between them is important. Radical surgery is required for primary lesions, while the treatment for metastatic melanomas is palliative. Unfortunately, 80% of laryngeal malignant melanomas are metastatic at the time of diagnosis. 7 The overall 5-year survival rate for mucosal melanoma is 15 to 20%, with a 30.9% rate of 5-year survival for primary tumors located in the nasal cavity, 12.3% for oral cavity primaries, and 0% for paranasal sinus primaries. 4 Depth of invasion, regional lymphadenopathy, and the presence of distant metastases have not been shown to be of value in predicting survival for primary mucosal melanomas of the head and neck. 4, 9 Radiotherapy may be effective in local control of the disease but has no effect on survival, 4 and chemotherapy has not been found to be effective. 4, 6, 7 Regional lymph node metastasis is rare, and neck dissection is therefore not recommended. Most authors recommend tracheal resection in tracheal mucosal melanomas. 6, 7 However, the mass in our case was bound by a fi ne peduncle, unlike most cases described in the literature, and had no local or distant metastasis. 8 Therefore, we excised a 5-mm intact mucosal zone surrounding the peduncle and performed paratracheal lymph node dissection to reveal regional lymph node metastasis, if present. As the lymph nodes and surgical margins were clean, no additional treatment was necessary.
In conclusion, primary malignant melanoma may be seen in the trachea as a pedunculated mass with defi ned borders. In the present case, in which there was no evidence of metastasis, resection of the mass with a clean margin of mucosa appears to be an acceptable alternative to tracheal resection.
